Predicting binding affinity doesn’t work — or does it?

webinar

Tue, 16 Jun 2015, 19:00 CEST (Berlin)

Dr. Carsten Detering, BioSolveIT GmbH, St. Augustin, Germany

Predicting binding affinity doesn’t work — or does it?

Predicting binding affinity is still regarded as the holy grail. With SeeSAR, however, we are one step closer to accurately and reliably predict a protein-ligand’s binding affinity. What one often neglects is the accuracy of the data, and that, especially in brute force correlation analysis, we might compare apples with oranges.

SeeSAR will tell you where the problems are. So you can understand, without looking at any numbers, where you might have to optimize or where a crystal structure might not be credible. Because they are not, as Derek Lowe once put it, a “message from God”, but full of assumptions themselves. If we start to understand incorporate this in our work, we will see calculated binding affinity in a whole new (green) light.

Current news

CHEMriya Update November
November 11, 2026 11:19 CET
More Chemistry. More Possibilities. The latest update of CHEMriya brings over 794 billion virtual product molecules to your compound exploration. Developed by OTAVA in collaboration with BioSolveIT, this on-demand Chemical Space opens up new opportunities for hit expansion, hit-to-lead optimization, and compound evolution. The November 2026 release combines OTAVA’s chemistry...
Read on
category
Challenge
Winter 2026 Scientific Challenge Deadline Approaching
November 3, 2026 13:18 CET
The Winter 2026 Scientific Challenge is here! We invite researchers from academia (students, postdocs, and professors), non-profit organizations, and independent researchers to take part. Whether you are exploring a new drug discovery idea or looking to advance an existing project, our software can help you take your research further. How...
Read on
CORE by Onepot.AI – Access now with our tools
October 27, 2026 14:38 CET
Bringing Robotic Synthesis to Chemical Space Exploration A new Chemical Space is now available for your compound exploration: onepot’s CORE Space brings over 10 billion virtual product molecules to your drug discovery projects. CORE (Compounds On-demand via Robotic Execution) combines reactions widely used in medicinal chemistry with building blocks that...
Read on